-
AstraZeneca plc (/ˌæstrəˈzɛnəkə/) (AZ) is a British-Swedish
multinational pharmaceutical and
biotechnology company with its
headquarters at the Cambridge...
- The Oxford–
AstraZeneca COVID‑19 vaccine, sold
under the
brand names Covishield and
Vaxzevria among others, is a
viral vector vaccine for the prevention...
-
Stock Exchange. In 1999,
Zeneca and the Sweden-based
pharmaceutical company Astra AB
merged to form
AstraZeneca plc.
Zeneca's largest therapeutic area...
- Biovail's sustained-release
tablets will
compete with
AstraZeneca's Seroquel XR. In
December 2008,
AstraZeneca notified shareholders that the FDA had
asked for...
-
recognized by the
World Health Organization (WHO): Pfizer–BioNTech, Oxford–
AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia...
- by
Swedish AB Hässle, part of
Astra AB. It was the
first of the
proton pump
inhibitors (PPI).
Astra AB, now
AstraZeneca,
launched it as an
ulcer medicine...
- in 2001 and 2005, the drug
netted AstraZeneca about $14.4 billion.
There has been some
controversy about AstraZeneca's behaviour in creating, patenting...
-
increase the risk of side effects, a
study by the drug's manufacturer,
AstraZeneca, indicated." Therefore, the
lowest dose is
recommended in Asians. As...
- PMC 8143907. PMID 34062319. "
AstraZeneca COVID-19
Vaccine (AZD1222)" (PDF). ACIP COVID-19
Emergency Meeting.
AstraZeneca. 27
January 2021.
Archived (PDF)...
-
Australian use in 2021: the Pfizer–BioNTech
vaccine on 25 January, the Oxford–
AstraZeneca vaccine on 16 February,
Janssen vaccine on 25 June and the
Moderna vaccine...
